Feverfew: Migraine Prevention Evidence and Dosing

Feverfew (Tanacetum parthenium) is one of the most studied herbal supplements for migraine prevention, with a history of use in traditional European medicine stretching back centuries. Modern research has identified its active compounds, conducted multiple clinical trials, and defined the specific preparations most likely to be effective.

How Feverfew Works

The primary active compound in feverfew is parthenolide, a sesquiterpene lactone found in the leaves. Parthenolide works through several mechanisms relevant to migraine pathophysiology:

Serotonin inhibition: Feverfew inhibits serotonin release from platelets and white blood cells. Serotonin fluctuations are a key trigger for cortical spreading depression (the electrochemical event underlying migraines with aura).

Prostaglandin reduction: By inhibiting phospholipase A2, feverfew reduces production of pro-inflammatory prostaglandins that sensitize trigeminal pain fibers.

Platelet aggregation inhibition: Feverfew reduces platelet stickiness and aggregation, improving cerebrovascular blood flow.

NF-kB suppression: Parthenolide inhibits NF-kB, a master regulator of inflammatory signaling in the CNS.

Clinical Trial Evidence

The evidence for feverfew in migraine prevention is positive but inconsistent, largely due to differences in preparation quality and parthenolide content across studies.

A landmark double-blind crossover trial published in The Lancet found that patients who switched from raw feverfew to placebo experienced a significant increase in migraine frequency and severity, confirming a real preventive effect. Multiple subsequent trials found 50% responder rates (at least 50% reduction in headache frequency) in roughly 40-60% of participants.

A Cochrane review of six trials concluded that feverfew is likely effective for migraine prevention, with a modest but consistent effect size. The review emphasized that preparation quality — specifically parthenolide content — is critical to outcomes.

Dosage and Standardization

Dosage: 50-150 mg/day of standardized feverfew extract containing 0.2-0.6% parthenolide.

Dried leaf preparations (traditionally used in the UK, where patients chew 2-3 fresh leaves daily) are less consistent due to variable parthenolide content. Standardized extracts provide more reliable dosing.

Allow 4-8 weeks before expecting measurable reductions in migraine frequency. Full benefit typically develops over 3-6 months.

Forms and Quality

Not all feverfew products are equal. Key considerations:

Standardized parthenolide: Look for at least 0.2% parthenolide content
Avoid CO2 extracts: Some extraction methods destroy parthenolide
MIG-99: A specific CO2 extract with documented efficacy in trials; different from standard extracts
Fresh vs. dried: Fresh feverfew leaves have the highest parthenolide, but consistency is poor

Side Effects and Cautions

Feverfew is generally well-tolerated. The most common side effect is mouth ulceration when chewing fresh leaves (avoided with capsules). Some users report mild GI discomfort.

Important cautions:

Do not use during pregnancy (uterine stimulant effects)
Discontinue 2 weeks before surgery (antiplatelet effects)
Avoid if allergic to ragweed, chrysanthemums, or related plants (Asteraceae family)
Abrupt discontinuation after long-term use can cause "post-feverfew syndrome" — rebound headaches, anxiety, and insomnia. Taper gradually.

Combining Feverfew with Other Migraine Supplements

Feverfew is frequently combined with magnesium and riboflavin as a triple-therapy approach. One commercial product (MigreLief) combines all three and has positive clinical feedback. There are no significant interactions between these compounds.

FAQ

Q: Can feverfew be used for acute migraine relief? A: No. Feverfew is strictly preventive and should be taken daily regardless of whether a migraine is present. It is not effective for treating an active migraine attack.

Q: Is feverfew safe for long-term use? A: Clinical trials up to 4 months show a good safety profile. Long-term use (years) has not been formally studied, but given its traditional use history, extended use appears safe for most people. Annual breaks are sometimes recommended to assess continued need.

Q: How does feverfew compare to butterbur for migraine prevention? A: Butterbur (PA-free) has slightly stronger clinical trial evidence than feverfew. Both work through anti-inflammatory and platelet-modulatory mechanisms. Combining them may not offer additive benefit and is generally unnecessary — choose the one that suits your tolerance and safety profile.

Track your supplements in Optimize.